TAMA HOME CO LTD by TAMA HOME CO LTD. Stock (OTC: TMAHF)

Latest news for TAMA HOME CO LTD by TAMA HOME CO LTD. (OTC:TMAHF) Stock

TAMA HOME CO LTD by TAMA HOME CO LTD.

<ul>
<li>Quarterly dividend rate has grown at a CAGR of 8.8% over the last five years</li>
</ul>
On July 30, 2024, the Board of Directors of American States Water Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AWR#NYSE">AWR</a>) approved an increase in the company's third quarter cash dividend to $0.4655 per share from $0.4300 per share on the common shares of the company. The annualized dividend rate after this increase is $1.862 per share, which represents an 8.3% increase from the current annualized dividend rate of $1.72 per share.

News

Dividends

American States Water Company Increases Quarterly Dividend From $0.43 To $0.4655 Per Share

HC Wainwright &amp; Co. analyst Andrew Fein reiterates Fulcrum Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FULC#NASDAQ">FULC</a>) with a Buy and maintains $17 price target.

Price Target

Reiteration

Analyst Ratings

FULC

HC Wainwright & Co. Reiterates Buy on Fulcrum Therapeutics, Maintains $17 Price Target

PCG Digital -- Soligenix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>), a late-stage biopharmaceutical company, is making significant strides in the treatment of Cutaneous T-Cell Lymphoma (CTCL) with its investigational drug, HyBryte&#x2122;. In an exclusive interview, PCG Digital speaks with Dr. Brian Poligone, Director of the Rochester Skin Lymphoma Medical Group and Principal Investigator for Soligenix's comparative study, who shares insights on the promising advancements.
&nbsp;
&nbsp;
Soligenix plans to initiate patient enrollment in the confirmatory FLASH 2 study with HyBryte&#x2122; by the end of 2024. The company continues to explore the potential of HyBryte&#x2122; in treating other dermatological conditions such as psoriasis, where it has a Phase 2 study ongoing, demonstrating its commitment to expanding treatment options for patients with skin diseases.

Biotech

General

SNGX

Soligenix Plans To Initiate Patient Enrollment In The Confirmatory FLASH 2 Study With HyBryte By The End Of 2024; Continues To Explore The Potential Of HyBryte In Treating Other Dermatological Conditions Such As Psoriasis

Wells Fargo analyst Zachary Fadem upgrades Carvana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) from Equal-Weight to Overweight and raises the price target from $77 to $175.

Upgrades

CVNA

Wells Fargo Upgrades Carvana to Overweight, Raises Price Target to $175

WIIM

RDDT

Reddit shares are trading higher after Loop Capital upgraded the stock from Hold to Buy.

Susquehanna analyst Shyam Patil maintains trivago (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVG#NASDAQ">TRVG</a>) with a Neutral and lowers the price target from $2.5 to $2.25.

TRVG

Susquehanna Maintains Neutral on trivago, Lowers Price Target to $2.25

<ul>
<li>ZTlido net sales for the month ended July 31, 2024 were in the range of $4.0 million to $5.0 million, compared to $2.7 million for the same period last year, representing growth in the range of approximately 48% to 85%. &nbsp;</li>
<li>Total product net sales for the month ended July 31, 2024 were in the range of $4.3 million to $5.3 million, compared to $2.8 million for the same period last year, representing growth in the range of approximately 54% to 89%. &nbsp;</li>
</ul>
PALO ALTO, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCLX#NASDAQ">SCLX</a>, "Scilex" or the "Company")))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today provided certain preliminary unaudited financial results for the month ended July 31, 2024. Scilex generates continuous sales growth in ZTlido&#xAE; going into third quarter of 2024 with preliminary net sales for ZTlido&#xAE; in the range of $4.0 million to $5.0 million.
The Company estimates that:
<ul>
<li>ZTlido net sales for the month ended July 31, 2024 were in the range of $4.0 million to $5.0 million, compared to $2.7 million for the same period last year, representing growth in the range of approximately 48% to 85%. &nbsp;</li>
<li>Total product net sales for the month ended July 31, 2024 were in the range of $4.3 million to $5.3 million, compared to $2.8 million for the same period last year, representing growth in the range of approximately 54% to 89%.</li>
</ul>

Earnings

Guidance

SCLX

Scilex Holding Company Preliminary Q3 ZTlido Net Sales $4M-$5M; Total Net Sales $4.3M-$5.3M

Susquehanna analyst Shyam Patil maintains Tenable Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TENB#NASDAQ">TENB</a>) with a Positive and lowers the price target from $60 to $48.

TENB

Susquehanna Maintains Positive on Tenable Holdings, Lowers Price Target to $48

HC Wainwright &amp; Co. analyst Andrew Fein reiterates Syros Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRS#NASDAQ">SYRS</a>) with a Buy and maintains $15 price target.

SYRS

HC Wainwright & Co. Reiterates Buy on Syros Pharmaceuticals, Maintains $15 Price Target

AerCap Holdings N.V. shares are trading higher after the company reported better-than-expected Q2 adjusted EPS results and raised its FY24 adjusted EPS guidance. Additionally, the company announced the delivery of the first three of fifteen new Airbus A321neo aircrafts.

LIPO

Lipella Pharmaceuticals shares are trading lower after the company announced a $1.28 million registered direct offering of 2.066 million shares of common stock at $0.62/share

Partnership Integrates Beeline's Workforce Management Solutions With Upwork's Talent Marketplace, Offering Access To Over 10,000 Skills And 125 Categories Of Work, Streamlining Sourcing, Hiring, Onboarding, And Payment Processes

UPWK

Beeline And Upwork Announce Strategic Partnership To Enhance Hiring Efficiency And Centralize Contingent Workforce Programs

Susquehanna analyst Joseph Stauff maintains MGM Resorts Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGM#NYSE">MGM</a>) with a Positive and raises the price target from $54 to $55.

Susquehanna Maintains Positive on MGM Resorts Intl, Raises Price Target to $55

SunCar Technology Group Inc. ((", SunCar", , NASDAQ:<a href="https://www.benzinga.com/stock/SDA#NASDAQ">SDA</a>), an innovative leader in cloud-based B2B auto services and auto e-insurance in China, is pleased to announce the formation of a new business partnership with the Inner Mongolia branch of China Continent Property &amp; Casualty Insurance Co., Ltd ("China Continent Insurance"). China Continent Insurance is the only subsidiary of China Reinsurance (Group) Corporation (SEHK: 1508) that specializes in non-life primary insurance. This partnership marks a significant addition to SunCar's existing collaborations with over 20 branches of China Continent Insurance across multiple major cities and provinces in China.
This expansion contributed to a remarkable increase in service sales, with a more than 30% rise in the first half of 2024 compared to the same period in 2023, underscoring the strength and success of SunCar's continuing efforts to expand its partnerships.

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

SunCar Expands Partnership With The Inner Mongolia Branch Of China Continent Property & Casualty Insurance Co., Ltd, Expansion Contributed To A Increase In Service Sales, With A More Than 30% Rise In The First Half Of 2024

Susquehanna analyst Shyam Patil maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Positive and raises the price target from $550 to $600.

Susquehanna Maintains Positive on Meta Platforms, Raises Price Target to $600

Air Products &amp; Chemicals Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>) reported <a target="_blank" href="https://www.benzinga.com/pressreleases/24/08/n40092845/air-products-reports-fiscal-2024-third-quarter-gaap-eps-of-3-13-and-adjusted-eps-of-3-20" rel="noreferrer noopener">third-quarter 2024 adjusted</a> EPS of $3.20, up 7% year-over-year, beating the consensus of $3.03.
Sales declined 2% YoY to $2.986 billion, missing the consensus of $3.035 billion due to 2% unfavorable currency and 1% lower energy cost pass-through.
Sales by segments: Americas $1.235 billion (-2% Y/Y), Europe $693 million (-2% Y/Y), and Asia $790 million (-4% Y/Y).
Operating profit rose 14.5% Y/Y to $737.6 million, and margin expanded by 347 bps to 24.7%
Adjusted EBITDA rose 5% Y/Y to $1.3 billion, with margins expanding 260 basis points to 42.4%.
Air Products' operating cash flow for the nine months ended June 30 totaled $2.689 billion, up from $2.203 billion in 2023.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/07/39709835/honeywells-1-81b-power-play-acquires-air-products-lng-tech-to-lead-energy-transition" rel="noreferrer noopener">Honeywell&#8217;s $1.81B Power Play: Acquires Air Products&#8217; LNG Tech to Lead Energy Transition</a>
Q4 Guidance: Air Products sees Adjusted EPS Of $3.33 to $3.63 versus consensus Of $3.53.
2024 Guidance: Air Products reaffirmed its Adjusted EPS outlook of $12.20-$12.50 versus the consensus of $12.23 and capital expenditures outlook of $5.0 billion-$5.5 billion.
Price Action: APD shares are trading higher by 6.88% at $282.00 premarket at the last check Thursday.

Equities

Movers

Air Products' Q3 Win: EPS Surge and Margin Expansion Set Stage for Promising Q4

The Federal Reserve&#8217;s potential interest-rate cut in September is causing a stir as it coincides with the upcoming presidential election. 
What Happened: The Federal Reserve&#8217;s potential move towards an interest-rate cut in September has stirred up political controversy. The central bank, which aims to remain impartial in political matters, is facing a challenging situation. A rate cut before the election could provoke Republicans and former President Donald Trump, while not implementing a necessary reduction could negatively impact the economy and upset Democrats, The Wall Street Journal <a href="https://www.wsj.com/economy/central-banking/fed-interest-rate-cut-inflation-politics-a6e527de?mod=hp_lead_pos4">reported</a> on Thursday.
Chair of the Federal Reserve, Jerome Powell, has been laying the groundwork for such a decision, stating that his focus is on ensuring the Fed can reduce inflation without causing a recession. He has earlier denied any political influence on the Fed&#8217;s decisions. 
&#8220;We never use our tools to support or oppose a political party, a politician or any political outcome,&#8221; Powell previously asserted.
The Federal Reserve had previously increased rates from near zero two years ago to combat inflation. The last increase in July 2023 brought the benchmark short-term interest rates to around 5.3%, a high not seen in two decades. These rate increases have coincided with significant drops in inflation.
However, the timing of the rate cuts could have significant political implications. Bond investors already expect at least two or possibly three rate cuts this year. But consumers with credit card debt and businesses that rely on short-term debt won&#8217;t see benefits until the Fed cuts rates. If the Fed fails to follow through with the expected September rate cut, borrowing costs could rise, and other financial conditions could tighten.
See Also: <a href="https://www.benzinga.com/news/large-cap/24/07/40080168/jerome-powell-finally-concedes-rate-cut-could-be-on-the-table-in-september-stocks-gold-rise-dollar?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Jerome Powell Finally Concedes &#8216;Rate Cut Could Be On The Table&#8217; In September: Stocks, Gold Rise, Dollar Falls</a>
Republicans have expressed concern that a rate cut in September could boost sentiment and provide Democrats with a positive talking point about the economy. Michael Faulkender, an economist at the Treasury Department during the Trump administration, suggested that waiting until after the election to implement the rate cut would have minimal impact.
Democrats, on the other hand, have voiced concerns that the presidential campaign of Vice President Kamala Harris won&#8217;t benefit from the recent slowdown in inflation due to the unpopularity of the Fed&#8217;s interest-rate measures. Some have urged Powell to cut rates now to prevent unnecessary economic weakness and increase the chances of a soft landing.
Despite the political debate, the Federal Reserve maintains that its decisions are based on data, outlook, and balance of risks, not political considerations. 
&#8220;Congress has, we believe, ordered us to conduct our business in a nonpolitical way at all times, not just some of the time,&#8221; Powell said.
Why It Matters: The Federal Reserve&#8217;s potential rate cut is not only a matter of economic concern but also a political one. The Fed is <a href="https://www.benzinga.com/news/24/07/40030097/jerome-powell-faces-trump-dilemma-over-potential-policy-shocks-amid-growing-election-uncertainty-say">grappling with the potential impact </a>of former President Donald Trump&#8216;s policy shocks on the economy and interest rates. This situation has created a dilemma for the Fed, which must consider the potential policy changes that could follow a second Trump presidency or a shift in balance with Vice President Kamala Harris.
The Biden administration has<a href="https://www.benzinga.com/government/24/05/38977914/biden-administration-backs-independent-federal-reserve-amid-trumps-alleged-plans-to-control-us-monet"> reaffirmed its support </a>for an autonomous Federal Reserve amid reports of Trump&#8217;s intentions to influence U.S. monetary policy. The White House Council for Economic Advisors underlined the importance of central bank independence, stating that central banks under political control perform poorly, while independent central banks are more effective in managing inflation.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/40008162/us-stocks-look-to-extend-gains-ahead-of-key-tech-earnings-fomc-meeting-analyst-says-this-could-serv?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Nasdaq, S&amp;P 500 To Start New Week In The Green: What&#8217;s Driving Sentiment</a></li>
</ul>
Image via Midjourney
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

Macro Economic Events

Economics

Despite Jerome Powell's Assurance, Federal Reserve's 'Nonpolitical Way' Of Rate Cuts Stirs Debate Among Trump And Harris' Supporters

LIQT

LiqTech International And China Haisum Engineering Sign MoU To Explore Application Of Advanced Filtration System For Industrial Water Treatment In China

Susquehanna analyst James Friedman maintains Mastercard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) with a Positive and raises the price target from $535 to $540.

Susquehanna Maintains Positive on Mastercard, Raises Price Target to $540

HC Wainwright &amp; Co. analyst Andrew Fein reiterates United Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UTHR#NASDAQ">UTHR</a>) with a Buy and maintains $400 price target.

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

TAMA HOME CO LTD by TAMA HOME CO LTD.

News

Latest news for TAMA HOME CO LTD by TAMA HOME CO LTD. (OTC:TMAHF) Stock